Logo image of 33L.DE

LULULEMON ATHLETICA INC (33L.DE) Stock Fundamental Analysis

Europe - FRA:33L - US5500211090 - Common Stock

136.2 EUR
-1.36 (-0.99%)
Last: 9/15/2025, 7:00:00 PM
Fundamental Rating

7

Taking everything into account, 33L scores 7 out of 10 in our fundamental rating. 33L was compared to 45 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the health and profitability get an excellent rating, making 33L a very profitable company, without any liquidiy or solvency issues. 33L scores decently on growth, while it is valued quite cheap. This could make an interesting combination. This makes 33L very considerable for value and quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

33L had positive earnings in the past year.
33L had a positive operating cash flow in the past year.
Each year in the past 5 years 33L has been profitable.
In the past 5 years 33L always reported a positive cash flow from operatings.
33L.DE Yearly Net Income VS EBIT VS OCF VS FCF33L.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

1.2 Ratios

With an excellent Return On Assets value of 23.74%, 33L belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 40.70%, 33L belongs to the top of the industry, outperforming 95.56% of the companies in the same industry.
33L's Return On Invested Capital of 29.67% is amongst the best of the industry. 33L outperforms 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 33L is significantly above the industry average of 10.76%.
Industry RankSector Rank
ROA 23.74%
ROE 40.7%
ROIC 29.67%
ROA(3y)20.32%
ROA(5y)18.95%
ROE(3y)35.25%
ROE(5y)32.87%
ROIC(3y)29.73%
ROIC(5y)26.99%
33L.DE Yearly ROA, ROE, ROIC33L.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

33L has a better Profit Margin (16.38%) than 91.11% of its industry peers.
In the last couple of years the Profit Margin of 33L has remained more or less at the same level.
33L's Operating Margin of 22.92% is amongst the best of the industry. 33L outperforms 91.11% of its industry peers.
33L's Operating Margin has been stable in the last couple of years.
With a Gross Margin value of 59.10%, 33L is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
33L's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 22.92%
PM (TTM) 16.38%
GM 59.1%
OM growth 3Y2.55%
OM growth 5Y1.15%
PM growth 3Y3.21%
PM growth 5Y1.1%
GM growth 3Y0.89%
GM growth 5Y1.17%
33L.DE Yearly Profit, Operating, Gross Margins33L.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

9

2. Health

2.1 Basic Checks

33L has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, 33L has less shares outstanding
The number of shares outstanding for 33L has been reduced compared to 5 years ago.
33L has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
33L.DE Yearly Shares Outstanding33L.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
33L.DE Yearly Total Debt VS Total Assets33L.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

An Altman-Z score of 7.26 indicates that 33L is not in any danger for bankruptcy at the moment.
33L's Altman-Z score of 7.26 is amongst the best of the industry. 33L outperforms 88.89% of its industry peers.
There is no outstanding debt for 33L. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.26
ROIC/WACC3.07
WACC9.66%
33L.DE Yearly LT Debt VS Equity VS FCF33L.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.3 Liquidity

33L has a Current Ratio of 2.27. This indicates that 33L is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.27, 33L belongs to the best of the industry, outperforming 84.44% of the companies in the same industry.
33L has a Quick Ratio of 1.16. This is a normal value and indicates that 33L is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.16, 33L is in the better half of the industry, outperforming 68.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 1.16
33L.DE Yearly Current Assets VS Current Liabilites33L.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.88% over the past year.
33L shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.37% yearly.
Looking at the last year, 33L shows a quite strong growth in Revenue. The Revenue has grown by 9.16% in the last year.
33L shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.62% yearly.
EPS 1Y (TTM)8.88%
EPS 3Y23.52%
EPS 5Y24.37%
EPS Q2Q%-1.59%
Revenue 1Y (TTM)9.16%
Revenue growth 3Y19.17%
Revenue growth 5Y21.62%
Sales Q2Q%6.5%

3.2 Future

Based on estimates for the next years, 33L will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.14% on average per year.
The Revenue is expected to grow by 6.76% on average over the next years.
EPS Next Y0.54%
EPS Next 2Y3.51%
EPS Next 3Y4.14%
EPS Next 5Y10.14%
Revenue Next Year4.37%
Revenue Next 2Y4.58%
Revenue Next 3Y4.82%
Revenue Next 5Y6.76%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
33L.DE Yearly Revenue VS Estimates33L.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
33L.DE Yearly EPS VS Estimates33L.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10 20 30

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.90, which indicates a very decent valuation of 33L.
Compared to the rest of the industry, the Price/Earnings ratio of 33L indicates a rather cheap valuation: 33L is cheaper than 91.11% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.27, 33L is valued rather cheaply.
A Price/Forward Earnings ratio of 10.17 indicates a reasonable valuation of 33L.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 33L indicates a rather cheap valuation: 33L is cheaper than 95.56% of the companies listed in the same industry.
33L is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.77, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.9
Fwd PE 10.17
33L.DE Price Earnings VS Forward Price Earnings33L.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

77.78% of the companies in the same industry are more expensive than 33L, based on the Enterprise Value to EBITDA ratio.
33L's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. 33L is cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.27
EV/EBITDA 5.99
33L.DE Per share data33L.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 33L does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of 33L may justify a higher PE ratio.
PEG (NY)20.21
PEG (5Y)0.45
EPS Next 2Y3.51%
EPS Next 3Y4.14%

0

5. Dividend

5.1 Amount

No dividends for 33L!.
Industry RankSector Rank
Dividend Yield N/A

LULULEMON ATHLETICA INC

FRA:33L (9/15/2025, 7:00:00 PM)

136.2

-1.36 (-0.99%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)09-04 2025-09-04/amc
Earnings (Next)12-03 2025-12-03/amc
Inst Owners96.18%
Inst Owner ChangeN/A
Ins Owners0.31%
Ins Owner ChangeN/A
Market Cap16.15B
Analysts73.85
Price Target178.93 (31.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.13%
Min EPS beat(2)-1.37%
Max EPS beat(2)5.62%
EPS beat(4)3
Avg EPS beat(4)2.97%
Min EPS beat(4)-1.37%
Max EPS beat(4)5.62%
EPS beat(8)7
Avg EPS beat(8)4.26%
EPS beat(12)10
Avg EPS beat(12)4.28%
EPS beat(16)14
Avg EPS beat(16)5.09%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-2.5%
Max Revenue beat(2)-1.43%
Revenue beat(4)0
Avg Revenue beat(4)-1.28%
Min Revenue beat(4)-2.5%
Max Revenue beat(4)-0.26%
Revenue beat(8)0
Avg Revenue beat(8)-1.59%
Revenue beat(12)3
Avg Revenue beat(12)-0.84%
Revenue beat(16)5
Avg Revenue beat(16)-0.43%
PT rev (1m)-30.6%
PT rev (3m)-39.8%
EPS NQ rev (1m)-20.58%
EPS NQ rev (3m)-20.56%
EPS NY rev (1m)-0.69%
EPS NY rev (3m)-2.01%
Revenue NQ rev (1m)-2.56%
Revenue NQ rev (3m)-3.15%
Revenue NY rev (1m)-1.9%
Revenue NY rev (3m)-2.25%
Valuation
Industry RankSector Rank
PE 10.9
Fwd PE 10.17
P/S 1.74
P/FCF 16.27
P/OCF 9.94
P/B 4.33
P/tB 4.52
EV/EBITDA 5.99
EPS(TTM)12.5
EY9.18%
EPS(NY)13.39
Fwd EY9.83%
FCF(TTM)8.37
FCFY6.15%
OCF(TTM)13.7
OCFY10.06%
SpS78.15
BVpS31.45
TBVpS30.14
PEG (NY)20.21
PEG (5Y)0.45
Profitability
Industry RankSector Rank
ROA 23.74%
ROE 40.7%
ROCE 41.88%
ROIC 29.67%
ROICexc 36.8%
ROICexgc 38.25%
OM 22.92%
PM (TTM) 16.38%
GM 59.1%
FCFM 10.71%
ROA(3y)20.32%
ROA(5y)18.95%
ROE(3y)35.25%
ROE(5y)32.87%
ROIC(3y)29.73%
ROIC(5y)26.99%
ROICexc(3y)45.65%
ROICexc(5y)41.54%
ROICexgc(3y)46.74%
ROICexgc(5y)45.9%
ROCE(3y)41.97%
ROCE(5y)38.1%
ROICexcg growth 3Y-2.73%
ROICexcg growth 5Y3.8%
ROICexc growth 3Y3.22%
ROICexc growth 5Y3.16%
OM growth 3Y2.55%
OM growth 5Y1.15%
PM growth 3Y3.21%
PM growth 5Y1.1%
GM growth 3Y0.89%
GM growth 5Y1.17%
F-Score6
Asset Turnover1.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 154.46%
Cap/Sales 6.82%
Interest Coverage 250
Cash Conversion 64.15%
Profit Quality 65.41%
Current Ratio 2.27
Quick Ratio 1.16
Altman-Z 7.26
F-Score6
WACC9.66%
ROIC/WACC3.07
Cap/Depr(3y)181.68%
Cap/Depr(5y)168.92%
Cap/Sales(3y)7.05%
Cap/Sales(5y)6.53%
Profit Quality(3y)77.23%
Profit Quality(5y)86.23%
High Growth Momentum
Growth
EPS 1Y (TTM)8.88%
EPS 3Y23.52%
EPS 5Y24.37%
EPS Q2Q%-1.59%
EPS Next Y0.54%
EPS Next 2Y3.51%
EPS Next 3Y4.14%
EPS Next 5Y10.14%
Revenue 1Y (TTM)9.16%
Revenue growth 3Y19.17%
Revenue growth 5Y21.62%
Sales Q2Q%6.5%
Revenue Next Year4.37%
Revenue Next 2Y4.58%
Revenue Next 3Y4.82%
Revenue Next 5Y6.76%
EBIT growth 1Y8.67%
EBIT growth 3Y22.21%
EBIT growth 5Y23.02%
EBIT Next Year19.97%
EBIT Next 3Y9.65%
EBIT Next 5Y9.02%
FCF growth 1Y20.52%
FCF growth 3Y16.77%
FCF growth 5Y32.6%
OCF growth 1Y16.98%
OCF growth 3Y17.83%
OCF growth 5Y27.7%